Stock Acquisition Rights for Officers and Employees and Staged Vesting
First written in FY2022-Q2. 11 of 13 entries say "Advanced", first in FY2022-Q3. Latest entry: 2026-06-03.
- 2026-06-03RestatedGeneral Meetings of Shareholders
「Outside directors 18,537 shares 3 people」
The disclosure presents the distribution of shares to outside directors, reconfirming the operation of the share-based compensation program for officers. - FY2026-H1AdvancedAnnual report
「16 June 2025 (Note) 2. Through a private placement. Allottees: Directors and employees of the Company and its subsidiaries; number of shares issued: 302,582 common shares」
Issued 302,582 shares through a private placement to directors and employees, and also reported an increase of 9,166 shares resulting from the exercise of stock options. - FY2025AdvancedAnnual report
「RSUs granted to eligible recipients during the consolidated fiscal year are accounted for as equity-settled share-based compensation. The expense recognized in the consolidated income statement for the consolidated fiscal year was ¥525 million.」
In addition to the exercise of existing stock acquisition rights, 928,225 RSUs and 280,131 PSUs were granted in fiscal 2024, expanding the operation of the share-based compensation program. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note) Increase resulting from the exercise of stock options.」
During the interim consolidated accounting period, the number of shares outstanding increased by 100,157 through the exercise of stock options, and the rollout of share-based compensation progressed. - FY2024AdvancedAnnual report
「The increase in the number of issued common shares during the consolidated fiscal year resulted from the issuance of 638,860 new shares upon the exercise of stock acquisition rights and the issuance of 83,337 new shares upon the vesting of restricted stock units.」
The rollout of share-based compensation progressed through the exercise of stock acquisition rights and the vesting of RSUs. In addition, 41,400 shares under the second series of J-class stock acquisition rights were granted to 3 outside directors. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 30,912 shares Increase resulting from the exercise of stock options.」
30,912 shares were added in the third quarter through the exercise of stock options, and the rollout of share-based compensation for officers, employees and others is progressing. - FY2024-Q2AdvancedAnnual report
「The stock acquisition rights issued to the rights holders will vest for each tranche at the percentages shown in the table below on each vesting date shown in the table.」
Introduced a new structure granting stock acquisition rights equivalent to 41,400 common shares to 3 independent outside directors, with one-third vesting on each of 1 June 2024, 1 June 2025 and 1 June 2026. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 (Note) 1. Increase resulting from the exercise of stock options.」
During the first quarter, 223,439 shares were added through the exercise of stock options, and 83,337 shares were also issued through a private placement to directors and employees. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 96,872 shares Increase resulting from the exercise of stock options.」
96,872 shares were added to the number of shares outstanding in the third quarter through the exercise of stock options. - FY2023-Q2AdvancedAnnual report
「The stock acquisition rights issued to the rights holders will vest for each tranche at the percentages shown in the table below on each vesting date shown in the table.」
Granted stock acquisition rights equivalent to 37,800 shares to 3 independent outside directors, with one-third vesting on each of 1 June 2023, 1 June 2024 and 1 June 2025 under a new structure. - FY2023-Q1AdvancedAnnual report
「Allottees: Directors and employees of the Company and its subsidiaries; number of shares issued: 338,125 common shares」
Issued 338,125 shares through a private placement to directors and employees, and also reported an increase in shares resulting from the exercise of existing stock options. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 566,667 shares Increase resulting from the exercise of stock options.」
States that 566,667 shares were added to the number of shares outstanding in the third quarter through the exercise of stock options. - FY2022-Q2First statedAnnual report
「Number of share options (units) ※ 58,000」
The company granted 58,000 share options to executive officers and directors of subsidiaries, structured to vest in equal thirds on each vesting date in 2021, 2022, and 2023.